Among these, the circulating levels of majority of pro-inflammatory adipokines, such as leptin, IL-6 and tumour necrosis factor alpha (TNF-a) are increased in cancers, while some adipokines such as adiponectin are protective against tumourigenesis and its serum levels are usually decreased in the patients with cancer [45]. This evidence concerns the gene ADIPOQ and cancer.